MTOR and colorectal carcinoma: In summary, we speculated that by inhibiting the combination of PD1 and PD-L1, the function of T cells can be restored, which inhibits the abnormal activation of PI3K/mTOR and MAPK pathways, reduces CRC cell proliferation/migration, and promotes apoptosis.